Skip to main content
Top
Published in: Inflammation 6/2011

01-12-2011

Dynamics of Inflammatory Markers in Post-Acute Stroke Patients Undergoing Rehabilitation

Authors: Bogdan Nicolae Manolescu, Mihai Berteanu, Luminița Dumitru, Horațiu Dinu, Alina Iliescu, Ileana Cornelia Fărcășanu, Eliza Oprea, Suzana Vlădoiu, Oana Popa, Olga Ianăș

Published in: Inflammation | Issue 6/2011

Login to get access

Abstract

Stroke is a pathological condition associated with an enhanced inflammatory response that has a multifactorial etiology. We evaluated the dynamic of plasma concentrations of IL-1α, IL-6, IL-8, TNF-α, soluble form of intercellular adhesion molecule 1, and lipoprotein (a) [Lp(a)] during the rehabilitation of post-acute stroke patients (n = 20), in parallel with control subjects (n = 24). Stroke patients had significantly increased concentrations of IL-6, TNF-α, and Lp(a) when compared to healthy controls. It was found that the changes in the IL-6, IL-8, and TNF-α concentrations associated with the pathological condition were statistically significant (χ 2 = 4.81, p = 0.028, χ 2 = 10.40, p = 0.005 and χ 2 = 6.73, p = 0.034, respectively). The decrease of Lp(a) during the rehabilitation had statistical significance (p = 0.043), while the decrease of IL-1α had marginal significance (p = 0.071). IL-1α, TNF-α, and Lp(a) concentrations were significantly negatively correlated with the Barthel index values, suggesting that the decrease of these inflammatory markers was beneficial for patients’ recovery.
Literature
1.
go back to reference De Simoni, M.G., P. Milia, M. Barba, A. De Luigi, L. Parnetti, and V. Gallai. 2002. The inflammatory response in cerebral ischemia: Focus on cytokines in stroke patients. Clinical and Experimental Hypertension 24: 535–542.PubMedCrossRef De Simoni, M.G., P. Milia, M. Barba, A. De Luigi, L. Parnetti, and V. Gallai. 2002. The inflammatory response in cerebral ischemia: Focus on cytokines in stroke patients. Clinical and Experimental Hypertension 24: 535–542.PubMedCrossRef
2.
go back to reference Doyle, K.P., R.P. Simon, and M.P. Stenzel-Poore. 2008. Mechanisms of ischemic brain damage. Neuropharmacology 55: 310–318.PubMedCrossRef Doyle, K.P., R.P. Simon, and M.P. Stenzel-Poore. 2008. Mechanisms of ischemic brain damage. Neuropharmacology 55: 310–318.PubMedCrossRef
3.
go back to reference Wong, C.H., and P.J. Crack. 2008. Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury. Current Medicinal Chemistry 15: 1–14.PubMedCrossRef Wong, C.H., and P.J. Crack. 2008. Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury. Current Medicinal Chemistry 15: 1–14.PubMedCrossRef
4.
go back to reference Song, Y.S., M.S. Kim, H.A. Kim, B.I. Jung, J. Yang, P. Narasimhan, G.S. Kim, J.E. Jung, E.H. Park, and P.H. Chan. 2010. Oxidative stress increases phosphorylation of IkappaB kinase-alpha by enhancing NF-kappaB-inducing kinase after transient focal cerebral ischemia. Journal of Cerebral Blood Flow & Metabolism. doi:10.1038/jcbfm.2010.6. Song, Y.S., M.S. Kim, H.A. Kim, B.I. Jung, J. Yang, P. Narasimhan, G.S. Kim, J.E. Jung, E.H. Park, and P.H. Chan. 2010. Oxidative stress increases phosphorylation of IkappaB kinase-alpha by enhancing NF-kappaB-inducing kinase after transient focal cerebral ischemia. Journal of Cerebral Blood Flow & Metabolism. doi:10.​1038/​jcbfm.​2010.​6.
5.
go back to reference Liu, K.J., and G.A. Rosenberg. 2005. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radical Biology & Medicine 39: 71–80.CrossRef Liu, K.J., and G.A. Rosenberg. 2005. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radical Biology & Medicine 39: 71–80.CrossRef
6.
go back to reference Jin, R., G. Yang, and G. Li. 2010. Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells. Journal of Leukocyte Biology 87: 779–789.PubMedCrossRef Jin, R., G. Yang, and G. Li. 2010. Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells. Journal of Leukocyte Biology 87: 779–789.PubMedCrossRef
7.
go back to reference Perera, M.N., H.K. Ma, S. Arakawa, D.W. Howells, R. Markus, C.C. Rowe, and G.A. Donnan. 2006. Inflammation following stroke. Journal of Clinical Neuroscience 13: 1–8.CrossRef Perera, M.N., H.K. Ma, S. Arakawa, D.W. Howells, R. Markus, C.C. Rowe, and G.A. Donnan. 2006. Inflammation following stroke. Journal of Clinical Neuroscience 13: 1–8.CrossRef
8.
go back to reference Jones, G.T., M. Deng, G.D. Hammond-Tooke, S.P.A. McCormick, and A.M. van Rij. 2009. Increased plasma lipoprotein(a) found in large-artery atherosclerotic, but not small-artery occlusive, stroke. Clinical Chemistry 55: 1888–1890.PubMedCrossRef Jones, G.T., M. Deng, G.D. Hammond-Tooke, S.P.A. McCormick, and A.M. van Rij. 2009. Increased plasma lipoprotein(a) found in large-artery atherosclerotic, but not small-artery occlusive, stroke. Clinical Chemistry 55: 1888–1890.PubMedCrossRef
9.
go back to reference Mahoney, F.I., and D.W. Barthel. 1965. Functional evaluation: The Barthel index. Maryland State Medical Journal 24: 61–69. Mahoney, F.I., and D.W. Barthel. 1965. Functional evaluation: The Barthel index. Maryland State Medical Journal 24: 61–69.
10.
go back to reference Adams, H.P., B.H. Bendixen, L.J. Kappelle, J. Biller, B.B. Love, D.L. Gordon, and E.E. Marsh. 1993. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24: 35–41.PubMedCrossRef Adams, H.P., B.H. Bendixen, L.J. Kappelle, J. Biller, B.B. Love, D.L. Gordon, and E.E. Marsh. 1993. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24: 35–41.PubMedCrossRef
11.
go back to reference Slemmer, J.E., J.J. Shacka, M.I. Sweeney, and J.T. Weber. 2008. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Current Medicinal Chemistry 15: 404–414.PubMedCrossRef Slemmer, J.E., J.J. Shacka, M.I. Sweeney, and J.T. Weber. 2008. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Current Medicinal Chemistry 15: 404–414.PubMedCrossRef
12.
go back to reference Tarkowski, E., L. Rosengren, C. Blomstrand, C. Wikkelsö, C. Jensen, S. Ekholm, and A. Tarkowski. 1995. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26: 1393–1398.PubMedCrossRef Tarkowski, E., L. Rosengren, C. Blomstrand, C. Wikkelsö, C. Jensen, S. Ekholm, and A. Tarkowski. 1995. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26: 1393–1398.PubMedCrossRef
13.
go back to reference Lakhan, S.E., A. Kirchgessner, and M. Hofer. 2009. Inflammatory mechanisms in ischemic stroke: Therapeutic approaches. Journal of Translational Medicine 7: 97–106.PubMedCrossRef Lakhan, S.E., A. Kirchgessner, and M. Hofer. 2009. Inflammatory mechanisms in ischemic stroke: Therapeutic approaches. Journal of Translational Medicine 7: 97–106.PubMedCrossRef
14.
go back to reference Ferrarese, C., P. Mascarucci, C. Zoia, R. Cavarretta, M. Frigo, B. Begni, F. Sarinella, L. Frattola, and M.G. de Simoni. 1999. Increased cytokine release from peripheral blood cells after acute stroke. Journal of Cerebral Blood Flow and Metabolism 19: 1004–1009.PubMed Ferrarese, C., P. Mascarucci, C. Zoia, R. Cavarretta, M. Frigo, B. Begni, F. Sarinella, L. Frattola, and M.G. de Simoni. 1999. Increased cytokine release from peripheral blood cells after acute stroke. Journal of Cerebral Blood Flow and Metabolism 19: 1004–1009.PubMed
15.
go back to reference Elkind, M.S., J. Cheng, T. Rundek, B. Boden-Albala, and R.L. Sacco. 2004. Leukocyte count predicts outcome after ischemic stroke: The northern Manhattan stroke study. Journal of Stroke and Cerebrovascular Diseases 13: 220–227.PubMedCrossRef Elkind, M.S., J. Cheng, T. Rundek, B. Boden-Albala, and R.L. Sacco. 2004. Leukocyte count predicts outcome after ischemic stroke: The northern Manhattan stroke study. Journal of Stroke and Cerebrovascular Diseases 13: 220–227.PubMedCrossRef
16.
go back to reference Wu, D., and S.N. Meydani. 2008. Age-associated changes in immune and inflammatory responses: Impact of vitamin E intervention. Journal of Leukocyte Biology 84: 900–914.PubMedCrossRef Wu, D., and S.N. Meydani. 2008. Age-associated changes in immune and inflammatory responses: Impact of vitamin E intervention. Journal of Leukocyte Biology 84: 900–914.PubMedCrossRef
17.
go back to reference Kostulas, N., S.H. Pelidou, P. Kivisäkk, V. Kostulas, and H. Link. 1999. Increased IL-1β, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke 30: 2174–2179.PubMedCrossRef Kostulas, N., S.H. Pelidou, P. Kivisäkk, V. Kostulas, and H. Link. 1999. Increased IL-1β, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke 30: 2174–2179.PubMedCrossRef
18.
go back to reference Kettritz, R., M.L. Gaido, H. Haller, F.C. Luft, C.J. Jennette, and R.J. Falk. 1998. Interleukin-8 delays spontaneous and tumor necrosis factor-α-mediated apoptosis of human neutrophils. Kidney International 53: 84–91.PubMedCrossRef Kettritz, R., M.L. Gaido, H. Haller, F.C. Luft, C.J. Jennette, and R.J. Falk. 1998. Interleukin-8 delays spontaneous and tumor necrosis factor-α-mediated apoptosis of human neutrophils. Kidney International 53: 84–91.PubMedCrossRef
19.
go back to reference Acalovschi, D., T. Wiest, M. Hartmann, M. Farahmi, U. Mansmann, G.U. Auffarth, A.J. Grau, F.R. Green, C. Grond-Ginsbach, and M. Schwaninger. 2003. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 34: 1864–1869.PubMedCrossRef Acalovschi, D., T. Wiest, M. Hartmann, M. Farahmi, U. Mansmann, G.U. Auffarth, A.J. Grau, F.R. Green, C. Grond-Ginsbach, and M. Schwaninger. 2003. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 34: 1864–1869.PubMedCrossRef
20.
go back to reference Tarkowski, E., L. Rosengren, C. Blomstrand, C. Jensen, S. Ekholm, and A. Tarkowski. 1999. Intrathecal expression of proteins regulating apoptosis in acute stroke. Stroke 30: 321–327.PubMedCrossRef Tarkowski, E., L. Rosengren, C. Blomstrand, C. Jensen, S. Ekholm, and A. Tarkowski. 1999. Intrathecal expression of proteins regulating apoptosis in acute stroke. Stroke 30: 321–327.PubMedCrossRef
21.
go back to reference Vila, N., J. Castillo, A. Davalos, and A. Chamorro. 2003. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31: 2325–2329.CrossRef Vila, N., J. Castillo, A. Davalos, and A. Chamorro. 2003. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31: 2325–2329.CrossRef
22.
go back to reference Nakase, T., T. Yamazaki, N. Ogura, A. Suzuki, and K. Nagata. 2008. The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. Journal of the Neurological Sciences 271: 104–109.PubMedCrossRef Nakase, T., T. Yamazaki, N. Ogura, A. Suzuki, and K. Nagata. 2008. The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. Journal of the Neurological Sciences 271: 104–109.PubMedCrossRef
23.
go back to reference Dziedzic, T., A. Slowik, J. Pera, and A. Szczudlik. 2005. Interleukin 1 beta polymorphism (-511) and risk of stroke due to small vessel disease. Cerebrovascular Diseases 20: 299–303.PubMedCrossRef Dziedzic, T., A. Slowik, J. Pera, and A. Szczudlik. 2005. Interleukin 1 beta polymorphism (-511) and risk of stroke due to small vessel disease. Cerebrovascular Diseases 20: 299–303.PubMedCrossRef
24.
go back to reference Tong, Y., Y. Geng, J. Xu, Z. Wang, Y. Zhang, L. Lin, R. Zhang, P. Deng, Y. Li, W. Hou, Y. Chai, K.A. Mason, Z. Lu, and J. Cheng. 2010. The role of functional polymorphisms of the TNF-alpha gene promoter in the risk of ischemic stroke in Chinese Han and Uyghur populations: Two case-control studies. Clinica Chimica Acta. doi:10.1016/j.cca.2010.05.007. Tong, Y., Y. Geng, J. Xu, Z. Wang, Y. Zhang, L. Lin, R. Zhang, P. Deng, Y. Li, W. Hou, Y. Chai, K.A. Mason, Z. Lu, and J. Cheng. 2010. The role of functional polymorphisms of the TNF-alpha gene promoter in the risk of ischemic stroke in Chinese Han and Uyghur populations: Two case-control studies. Clinica Chimica Acta. doi:10.​1016/​j.​cca.​2010.​05.​007.
25.
go back to reference Al-Bahrani, A., S. Taha, H. Shaath, and M. Bakhiet. 2007. TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents. Current Neurovascular Research 4: 31–37.PubMedCrossRef Al-Bahrani, A., S. Taha, H. Shaath, and M. Bakhiet. 2007. TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents. Current Neurovascular Research 4: 31–37.PubMedCrossRef
26.
go back to reference Woodfin, A., M.B. Voisin, and S. Nourshargh. 2010. Recent developments and complexities in neutrophil transmigration. Current Opinion in Hematology 17: 9–17.PubMedCrossRef Woodfin, A., M.B. Voisin, and S. Nourshargh. 2010. Recent developments and complexities in neutrophil transmigration. Current Opinion in Hematology 17: 9–17.PubMedCrossRef
27.
go back to reference The Emerging Risk Factors Collaboration. 2009. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. Journal of the American Medical Association 302: 412–423.CrossRef The Emerging Risk Factors Collaboration. 2009. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. Journal of the American Medical Association 302: 412–423.CrossRef
28.
go back to reference Dechanet, J., C. Grosset, J.L. Taupin, P. Merville, J. Banchereau, J. Ripoche, and J.F. Moreau. 1997. CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells. Journal of Immunology 159: 5640–5647. Dechanet, J., C. Grosset, J.L. Taupin, P. Merville, J. Banchereau, J. Ripoche, and J.F. Moreau. 1997. CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells. Journal of Immunology 159: 5640–5647.
29.
go back to reference Poon, M., X. Zhang, K.G. Dunsky, M.B. Taubman, and P.C. Harpel. 1997. Apolipoprotein(a) induces chemotactic activity in human vascular endothelial cells. Circulation 96: 2514–2519.PubMed Poon, M., X. Zhang, K.G. Dunsky, M.B. Taubman, and P.C. Harpel. 1997. Apolipoprotein(a) induces chemotactic activity in human vascular endothelial cells. Circulation 96: 2514–2519.PubMed
30.
go back to reference Galvano, F., M. Malaguarnera, M. Vacante, M. Motta, C. Russo, G. Malaguarnera, N. D’Orazio, and L. Malaguarnera. 2010. The physiopathology of lipoprotein (a). Frontiers in Bioscience 2: 866–875.CrossRef Galvano, F., M. Malaguarnera, M. Vacante, M. Motta, C. Russo, G. Malaguarnera, N. D’Orazio, and L. Malaguarnera. 2010. The physiopathology of lipoprotein (a). Frontiers in Bioscience 2: 866–875.CrossRef
Metadata
Title
Dynamics of Inflammatory Markers in Post-Acute Stroke Patients Undergoing Rehabilitation
Authors
Bogdan Nicolae Manolescu
Mihai Berteanu
Luminița Dumitru
Horațiu Dinu
Alina Iliescu
Ileana Cornelia Fărcășanu
Eliza Oprea
Suzana Vlădoiu
Oana Popa
Olga Ianăș
Publication date
01-12-2011
Publisher
Springer US
Published in
Inflammation / Issue 6/2011
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-010-9262-8

Other articles of this Issue 6/2011

Inflammation 6/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine